News

In-Hospital Mortality Risk Increases With DIDO Time for STEMI Patients


 

FROM JAMA

The American College of Cardiology Foundation’s National Cardiovascular Data Registry sponsored the study. The ACTION Registry-GWTG is supported in part by the Bristol-Myers Squibb partnership. Dr. Wang reports receiving research grants from the BMS/Sanofi partnership, Schering Plough/Merck, The Medicines Company, Heartscape, Canyon Pharmaceuticals and Eli Lilly/Daiichi Sanyko Alliance, as well as consulting fees/honoraria from Medco and Astra Zeneca. Four of her coauthors report financial relationships with several drug firms.

Pages

Recommended Reading

Quality Guidelines Issued for Ambulatory Cardiac Care
MDedge Internal Medicine
Certain Antibodies Raise Rejection Risk in Heart Transplant Recipients
MDedge Internal Medicine
Simvastatin, Myalgias, and the QOD Solution
MDedge Internal Medicine
Ambulance Diversion Associated With Increased Heart Attack Mortality
MDedge Internal Medicine
Benefits of Perioperative Statins Borne Out in Trial
MDedge Internal Medicine
Aneurysm Complexity Influences Outcome
MDedge Internal Medicine
ALTITUDE Study: Inappropriate ICD Shocks Don't Increase Mortality
MDedge Internal Medicine
Diabetes Risk Rises as Statin Dose Increases
MDedge Internal Medicine
Fan Bids Cypher, the Sirolimus-Eluting Stent, Adieu
MDedge Internal Medicine
Fan Bids Cypher, the Sirolimus-Eluting Stent, Adieu
MDedge Internal Medicine